951 related articles for article (PubMed ID: 2882014)
1. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
Lehmann J; Schneider J; McPherson S; Murphy DE; Bernard P; Tsai C; Bennett DA; Pastor G; Steel DJ; Boehm C
J Pharmacol Exp Ther; 1987 Mar; 240(3):737-46. PubMed ID: 2882014
[TBL] [Abstract][Full Text] [Related]
2. CGS 19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonist.
Lehmann J; Hutchison AJ; McPherson SE; Mondadori C; Schmutz M; Sinton CM; Tsai C; Murphy DE; Steel DJ; Williams M
J Pharmacol Exp Ther; 1988 Jul; 246(1):65-75. PubMed ID: 2899170
[TBL] [Abstract][Full Text] [Related]
3. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.
Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET
J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669
[TBL] [Abstract][Full Text] [Related]
4. Action of 3-((+/-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP): a new and highly potent antagonist of N-methyl-D-aspartate receptors in the hippocampus.
Harris EW; Ganong AH; Monaghan DT; Watkins JC; Cotman CW
Brain Res; 1986 Sep; 382(1):174-7. PubMed ID: 2876750
[TBL] [Abstract][Full Text] [Related]
5. Guanine nucleotides are competitive inhibitors of N-methyl-D-aspartate at its receptor site both in vitro and in vivo.
Baron BM; Dudley MW; McCarty DR; Miller FP; Reynolds IJ; Schmidt CJ
J Pharmacol Exp Ther; 1989 Jul; 250(1):162-9. PubMed ID: 2545857
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs.
Snell LD; Johnson KM
J Pharmacol Exp Ther; 1986 Sep; 238(3):938-46. PubMed ID: 2875174
[TBL] [Abstract][Full Text] [Related]
7. Binding of [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid to rat brain membranes: a selective, high-affinity ligand for N-methyl-D-aspartate receptors.
Murphy DE; Schneider J; Boehm C; Lehmann J; Williams M
J Pharmacol Exp Ther; 1987 Mar; 240(3):778-84. PubMed ID: 3031274
[TBL] [Abstract][Full Text] [Related]
8. CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.
Fagg GE; Olpe HR; Pozza MF; Baud J; Steinmann M; Schmutz M; Portet C; Baumann P; Thedinga K; Bittiger H
Br J Pharmacol; 1990 Apr; 99(4):791-7. PubMed ID: 1972895
[TBL] [Abstract][Full Text] [Related]
9. Localization of N-methyl-D-aspartate receptors in the rat striatum: effects of specific lesions on the [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid binding.
Samuel D; Errami M; Nieoullon A
J Neurochem; 1990 Jun; 54(6):1926-33. PubMed ID: 2159977
[TBL] [Abstract][Full Text] [Related]
10. Homocysteic acid as a putative excitatory amino acid neurotransmitter: I. Postsynaptic characteristics at N-methyl-D-aspartate-type receptors on striatal cholinergic interneurons.
Lehmann J; Tsai C; Wood PL
J Neurochem; 1988 Dec; 51(6):1765-70. PubMed ID: 2846784
[TBL] [Abstract][Full Text] [Related]
11. Two classes of N-methyl-D-aspartate recognition sites: differential distribution and differential regulation by glycine.
Monaghan DT; Olverman HJ; Nguyen L; Watkins JC; Cotman CW
Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9836-40. PubMed ID: 2904680
[TBL] [Abstract][Full Text] [Related]
12. Muscle relaxant and anticonvulsant activity of 3-((+/-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid, a novel N-methyl-D-aspartate antagonist, in rodents.
Turski L; Klockgether T; Sontag KH; Herrling PL; Watkins JC
Neurosci Lett; 1987 Jan; 73(2):143-8. PubMed ID: 3029636
[TBL] [Abstract][Full Text] [Related]
13. Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative.
Singh L; Donald AE; Foster AC; Hutson PH; Iversen LL; Iversen SD; Kemp JA; Leeson PD; Marshall GR; Oles RJ
Proc Natl Acad Sci U S A; 1990 Jan; 87(1):347-51. PubMed ID: 2153294
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of N-methyl-D-aspartate (NMDA) evoked increases in cerebellar cGMP and striatal ACh release by phencyclidine (PCP) receptor agonists: evidence for possible allosteric coupling of NMDA and PCP receptors.
Wood PL; Steel D; McPherson SE; Cheney DL; Lehmann J
Can J Physiol Pharmacol; 1987 Sep; 65(9):1923-7. PubMed ID: 2825947
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist.
Ferkany JW; Kyle DJ; Willets J; Rzeszotarski WJ; Guzewska ME; Ellenberger SR; Jones SM; Sacaan AI; Snell LD; Borosky S
J Pharmacol Exp Ther; 1989 Jul; 250(1):100-9. PubMed ID: 2545856
[TBL] [Abstract][Full Text] [Related]
16. Neurochemical interactions of competitive N-methyl-D-aspartate antagonists with dopaminergic neurotransmission and the cerebellar cyclic GMP system: functional evidence for a phasic glutamatergic control of the nigrostriatal dopaminergic pathway.
Rao TS; Cler JA; Mick SJ; Emmett MR; Farah JM; Contreras PC; Iyengar S; Wood PL
J Neurochem; 1991 Mar; 56(3):907-13. PubMed ID: 1847188
[TBL] [Abstract][Full Text] [Related]
17. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain.
Foster AC; Wong EH
Br J Pharmacol; 1987 Jun; 91(2):403-9. PubMed ID: 2886170
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the binding of [3H]-CGS 19755: a novel N-methyl-D-aspartate antagonist with nanomolar affinity in rat brain.
Murphy DE; Hutchison AJ; Hurt SD; Williams M; Sills MA
Br J Pharmacol; 1988 Nov; 95(3):932-8. PubMed ID: 2850065
[TBL] [Abstract][Full Text] [Related]
19. Vinpocetine preferentially antagonizes quisqualate/AMPA receptor responses: evidence from release and ligand binding studies.
Kiss B; Cai NS; Erdö SL
Eur J Pharmacol; 1991 Dec; 209(1-2):109-12. PubMed ID: 1687679
[TBL] [Abstract][Full Text] [Related]
20. CGS 19755 is a potent and competitive antagonist at NMDA-type receptors.
Lehmann J; Chapman AG; Meldrum BS; Hutchison A; Tsai C; Wood PL
Eur J Pharmacol; 1988 Sep; 154(1):89-93. PubMed ID: 2846329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
